May 3rd 2017 - Gosselies, Belgium

From Big Data To Useful Knowledge

OncoDNA has the great pleasure to invite you to its third annual conference which will take place in Gosselies on May 3rd. This year, the topic will be “The integrated technologies in the fight against cancer – From big data to useful knowledge”.

You missed our event ? Don't worry...

3rd

Annual Conference

7

International Speakers

250

Special Guests

1

Cocktail Reception

about

About The Conference

OncoDNA has the pleasure to invite you to its annual conference which will take place in Gosselies on May 3rd 2017. This year, the topic will be “The integrated technologies in the fight against cancer – From big data to useful knowledge”.

Mr Jean-Claude Marcourt, Vice-President of the Walloon Government, Minister of the Economy, Industry, Innovation and Digital Affairs, Vice-President of the Government of the Wallonia-Brussels Federation, Minister for Higher Education, Research and Media, will be present as well as international scientific experts who will take this opportunity to share their opinion on this subject.

The Schedule

Timing and agenda of the event

  • 5:00 pm

    Registration and refreshments

  • schedule-speaker

    5:20 pm

    Event kickoff and welcoming address

    - By Nathalie Bernard

  • schedule-speaker

    5:25 pm

    A word about OncoDNA

    - By Jean-Pol Detiffe

  • schedule-speaker

    5:30 pm

    Introduction by Minister Jean-Claude Marcourt

    - By Jean-Claude Marcourt

  • schedule-speaker

    6:00 pm

    NGS analyses within the context of the Belgian healthcare system: challenges and opportunities

    Genomics is becoming a rapid reality in medical care. While oncology and genetics are taking the lead, other domains in healthcare will rapidly follow. There is thus a need for developing a framework for integrating this novel technology into our healthcare system in a sustainable, safe and acceptable way. In 2016, a roadbook has been prepared by the Cancer Centre of the Scientific Institute of Public Health for introducing NGS in (hemato) oncology trough a pilotstudy. We will discuss the different actions of the roadbook, present the first achievements of the pilotstudy and highlight future next steps in the process.

    - By Dr Marc Van den Bulcke 

  • schedule-speaker

    6:30 pm

    AGATA project - international OncoKDM pilot

    Introduction of the AGATA project and presentation of our collaboration and the platform

    - By Dr Sònia Pernas Simon, MD  

  • schedule-speaker

    7:00 pm

    Liquid Biopsies in Oncology and their Implementation in Cancer Management

    Overview of the latest findings from the field (from recently reported studies and ongoing trials) and our collaboration through AURORA (emphasizing also the educational component for treating physicians)

    - By Dr Dimitrios Zardavas

  • schedule-speaker

    7:30 pm

    Moncodaneum / OncoKDM discovery

    How to gather and transform the data used in routine into a very comprehensive report for the biologists and the clinicians.

    - By Dr Jean-François Laes

  • 8:00 pm

    Walking Dinner And Party

The Speakers

Experts who will be speaking at the event

event-speaker

Jean-Claude Marcourt

Minister, Walloon Region

View Bio
event-speaker

Dr Marc Van den Bulcke

Head of the Cancer Center

View Bio
event-speaker

Dr Sònia Pernas Simon, MD

Institut Català d'Oncologia

View Bio
event-speaker

Dr Dimitrios Zardavas

BIG Associate Medical Director

View Bio
event-speaker

Dr Jean-François Laes

OncoDNA CSO

View Bio
event-speaker

Jean-Pol Detiffe

OncoDNA CEO & Founder

View Bio
event-speaker

Nathalie Bernard

OncoDNA Marketing & Communication Director

View Bio

The Venue

OncoDNA

Institute of Pathology and Genetics

25, Avenue Georges Lemaître

6041 Gosselies - Belgium

+32 71 18 35 00

Hotels

Recommended hotels for stay during event

hotel

Aero 44 - Best Western

From 69€ / night

Breakfast - Free parking - Airport Shuttle

View on map
hotel

Ibis Budget - Charleroi Airport

From 47€ / night

Free Wi-Fi - Parking - Breakfast buffet

View on map
hotel

Hôtel Balladins - Charleroi Airport

From 120€ / night

Wi-Fi - Breakfast - Swimming pool

View on map

Send Us A Message

For more information, please fill in the contact form below :

Thank You! Your message has been sent.

Something went wrong, try refreshing and submitting the form again.

speaker Bio image

Jean-Claude Marcourt

Jean Claude Marcourt was born in Awans, on October 16, 1956. He is married, and has two children. He graduated in law from the University of Liège (1974-1979) and later became a lawyer at the Bar of Liège (on leave since 1992). He was first cabinet chief for many ministers between 1992 and 2004, and became minister in 2004. Since 2014, he has been Minister of Economy, Industry, Innovation and Digital Affairs, Vice President of the Walloon Government. Minister of Higher Education, Research and Media, Vice-President of the Government of the Wallonia-Brussels Federation

speaker Bio image

Nathalie Bernard

Doctorate in molecular genetics at UCL

Post-Doc in Montreal in human genetics at the Charles Bruneau Institute, specializing in pediatric cancers

19 years in biotech companies (ABI, Life Technologies, Thermo Fisher Scientific and Qiagen)

since October 2016 at OncoDNA

speaker Bio image

Jean-Pol Detiffe

CEO, 42, is a pharmacist and Qualified Person. He completed his education with an MBA from IAG-UCL and a post-graduate teaching diploma. Before setting up OncoDNA end of 2012, he worked in Quality Assistance, a service provider for the pharmaceutical industry, accredited ISO17025, certified GLP and inspected by the FDA. Over 6 years he held different posts in the company and their variety meant he was able to develop expertise in business development, organisation and management.

In 2004, with the help of ULB and IPG, he set up DNAVision, a company specialised in the development and validation of innovative DNA tests for the pharmaceutical and food industries. In two years, DNAVision became the first company in Europe to provide the pharmaceutical industry with ISO17025 accredited pharmacogenetic tests. DNAVision was certified GLP and GMP and also CLIA certified for analyses for the US.

speaker Bio image

Dr Marc Van den Bulcke

obtained a PhD in sciences at the Laboratory of Genetics, University of Ghent (Belgium). During his 10 years academic career, he gained broad experience in plant pathogen interactions, protein chemistry, molecular biology and cell biology. He worked for about 7 years within the biotech industry at Plant genetic Systems (now Bayer Crop Science) where he was involved in regulatory affairs and biotech product quality assurance. During this period, he gained real-life experience with global registration processes, accreditation, product quality control/assurance and business relationships. Since 2003, he works at the Scientific Institute of Public Health (Brussels, Belgium) where he supported the establishment of the National Reference Laboratory on GMO detection till 2009. He worked for 3 years as a contract agent at the ‘Institute of Health and Consumer Protection’ at the Joint Research Centre of the European Commission where he coordinated policy-support research in molecular detection.

Since 2013, he heads the Cancer Centre at the Scientific Institute of Public Health, a unit dedicated at the monitoring and evaluation of the activities in cancer control in Belgium. Current key activities of the Cancer Centre focus on the introduction of Next-Generation-Sequencing (NGS) in routine diagnostics in Belgium, on models to support the socio-professional reintegration of cancer patients, on developing a long-term strategy for cancer in Belgium, on screening and early detection (expert focus on cervical cancer) and on integrating patients, citizens and general practitioners in the policy support activities of the Cancer Centre.

In the joint action CanCon, the Cancer Centre has as principle task to coordinate the production of the final deliverable, a guide on quality improvement in cancer care. Also, we are responsible on developing a position paper on ‘Public Health Genomics in cancer’. The Cancer Centre is also partner in the new joint action on ‘Rare Cancers’.

speaker Bio image

Dr Sònia Pernas Simon, MD

Dr Sònia Pernas completed her University degree in Medicine and Surgery (MD) at University of Barcelona ( Spain) in 1999. After successfully completing her Medical Oncology internship and residency at Hospital de la Santa Creu i Sant Pau in Barcelona in 2004, Sònia joined the Breast Cancer Unit at Catalan Institute of Oncology, where she has been working as attending physician with full time dedication during the last 12 years. Since 2013, she is the head of the Breast Cancer Unit of this institution. She has extensive experience in clinical research, being involved in many phase 1 to 3 Breast Cancer clinical trials. Her field of research interest has focused on HER2-positive Breast Cancer. This interest is reflected in some of her publications and in the topic of her PhD thesis. Other fields of interest include biomarkers of response/resistance to therapy in breast cancer and identifying novel actionable target genes in order to develop rational combination of therapies. She is member of Executive Committee of SOLTI , since February 2015 and together with Dr Eva Ciruelos, she is the global Co-PI of the AGATA study, the first multi-institutional molecular screening program implemented in patients with advanced breast cancer in Spain.

speaker Bio image

Dr Dimitrios Zardavas

received his oncology training at the University Hospital of Zurich, Switzerland. He completed a research fellowship at Institut Jules Bordet, during which he commenced a PhD at the Université Libre de Bruxelles, Brussels, Belgium, focusing on PI3K pathway in breast cancer. Currently he works at Breast International Group as Associate Medical Director, designing and setting-up clinical trials in the field of breast cancer with emphasis on molecularly targeted agents. He is part of the core scientific team working for the AURORA initiative of molecular profiling for patients with advance breast cancer, sponsored by BIG’.

speaker Bio image

Dr Jean-François Laes

After a Phd in Genomics, Molecular Biology, Genetics at ULB, I worked during several years in different biotech companies (Life Technologies, DNA Vision, Biovallee). Since february 2013, I’m CTO (Chief Technological Officer) at OncoDNA. I'm responsible for establishing the OncoDNA’s technical vision and leading all aspects of the company’s technology development.

Close